ImmunoGen, Inc.

Links: Y! homepage Metavivor.org 501(c)(3) MBC Research & Support

IMGN / Message Board

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
50694	CX-2009 poster	GN	WilCravenMckrye		1	5/29/2020 9:31:27 AM

50693	Re: ImmunoGen Presents Initial Data at ASCO from FORWARD II Study Evaluating Mirvetuximab Soravtansine	GN	Bibliobiftek		0	5/29/2020 9:24:26 AM

50692	Re: ImmunoGen Presents Initial Data at ASCO from FORWARD II Study Evaluating Mirvetuximab Soravtansine	GN	WilCravenMckrye		4	5/29/2020 8:37:42 AM

50691	Re: ImmunoGen Presents Initial Data at ASCO from FORWARD II Study Evaluating Mirvetuximab Soravtansine	GN	WilCravenMckrye		0	5/29/2020 8:28:07 AM

50690	ImmunoGen Presents Initial Data at ASCO from FORWARD II Study Evaluating Mirvetuximab Soravtansine	GN	very		1	5/29/2020 8:10:25 AM

50689	Re: Mersana reporting promising PI data for NaPi2b expressing patients	GN	Bibliobiftek		1	5/28/2020 2:53:31 PM

50688	Re: Mersana reporting promising PI data for NaPi2b expressing patients	GN	Biotechbeagle		0	5/28/2020 2:17:12 PM

50687	bay94-9343	GN	jv08201		0	5/27/2020 3:09:18 PM

50686	Re: Mersana reporting promising PI data for NaPi2b expressing patients	GN	Bibliobiftek		0	5/27/2020 12:04:41 PM

50685	Mersana reporting promising PI data for NaPi2b expressing patients	GN	Bibliobiftek		0	5/27/2020 10:50:43 AM


	About Us • Contact Us • Follow Us on Twitter • Members Directory • Help Center • Advertise Not a member yet? What are you waiting for? Create Account Want to contribute? Support InvestorVillage by donating © 2003-2019 Investorvillage.com. All rights reserved. User Agreement